BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2309000)

  • 21. Clinical and laboratory comparison study of refrigerated and cryopreserved bone marrow for transplantation.
    Preti RA; Razis E; Ciavarella D; Fan Y; Kuhns RE; Cook P; Wong G; Wuest DL; Ahmed T
    Bone Marrow Transplant; 1994 Mar; 13(3):253-60. PubMed ID: 8199568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid storage of bone marrow.
    Mangalik A; Robinson WA; Drebing C; Hartmann D; Joshi JH
    Exp Hematol; 1979; 7 Suppl 5():76-94. PubMed ID: 400704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of bacterial contamination in bone marrow graft.
    D'Antonio D; Iacone A; Fioritoni G; Dragani A; Betti S; Quaglietta AM; Di Gianfilippo R; Accorsi P; Recchia A; Di Girolamo A
    Haematologica; 1991 Mar; 76 Suppl 1():44-5. PubMed ID: 1864553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cryopreservation of bone marrow for the autologous transplantation in children].
    Reiners B; Häfer R; Müller A; Hermann J; Fuchs D; Prager J; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):62-77. PubMed ID: 2439419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: an in vitro study to determine optimal timing of exposure to early acting cytokines.
    Ratajczak MZ; Ratajczak J; Kregenow DA; Gewirtz AM
    Stem Cells; 1994 Nov; 12(6):599-603. PubMed ID: 7533578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
    Schrøder H; Clausen N; Thorling K; Hokland P
    Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful infusion of 40 cryopreserved autologous bone-marrows. In vitro studies of the freezing procedure.
    Beaujean F; Hartmann O; Le Forestier C; Bayet S; Duédari N; Parmentier C
    Biomed Pharmacother; 1984; 38(7):348-52. PubMed ID: 6395915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryopreservation of marrow, purging and autologous bone marrow transplantation in childhood.
    Reiners B; Hermann J; Fuchs D; Prager J; Thränhardt H; Burger E; Kob D; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):601-8. PubMed ID: 2480316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
    Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
    Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and laboratory experience in marrow harvesting in children for autologous bone marrow transplantation.
    Cairo MS; VandeVen C; Toy C; Sender L
    Bone Marrow Transplant; 1989 May; 4(3):305-8. PubMed ID: 2659115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.
    Eder JP; Bast RC; Peters WP; Henner D; Sanchez E; Schryber S; Frei E; Schnipper LE
    Cancer Res; 1986 Sep; 46(9):4496-9. PubMed ID: 3524814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
    Bishop MR; Warkentin PI; Jackson JD; Bayever E; Iversen PL; Whalen VI; Lastovica J; Haines K; Kessinger A
    Prog Clin Biol Res; 1994; 389():183-7. PubMed ID: 7700901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.